BEGIN:VCALENDAR
VERSION:2.0
X-WR-CALNAME;VALUE=TEXT:Improving immune checkpoint therapy via Ab- and Glyco-targeting of melanoma stem cell-Tim-3
PRODID:-//Harvard events data//EN
BEGIN:VEVENT
UID:event_1571727_0
SUMMARY:Improving immune checkpoint therapy via Ab- and Glyco-targeting of melanoma stem cell-Tim-3
DESCRIPTION:<p>	<span style="color:#4e84c4;"><strong>HSCI Skin Program Spring Seminar Series </strong></span>(open to all members of the HSCI research community)</p><p>	Join us at:  <a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__partners.zoom.us_j_9240930305&amp;d=DwMF-g&amp;c=WO-RGvefibhHBZq3fL85hQ&amp;r=OyLCeamb-792r0mDmEPlznICanPJjNHKbLAl0btfDmo&amp;m=cZqyZ-rzQlwGHqSZFMoqk8efUQhkV__KAFP2xNvLHJ4&amp;s=exLD3igKCHtvHN2jIO6BncOIVQRV5wPBs8RssZqsrMA&amp;e=">https://partners.zoom.us/j/9240930305</a></p><p>	<strong>Guest speaker:<br><em>Steven R. Barthel, PhD</em></strong><br>Instructor in Dermatology<br>Brigham and Women's Hospital</p><p>	Dr. Barthel’s interdisciplinary expertise and ongoing research in glycobiology, galectins, melanoma/skin cancer, cancer stem cells, signaling, metastasis and biomarkers underlies his overall career and research goals to (1) characterize carbohydrate mediators of cancer progression and immune diseases, (2) identify and develop therapies to treat and diagnose cancer and inflammation, and to (3) mentor/train the next-generation of researchers in cancer and immunology.</p>
LOCATION:Via Zoom
STATUS:CONFIRMED
DTSTART:20210219T210000Z
DTEND:20210219T220000Z
END:VEVENT
END:VCALENDAR